Trials / Unknown
UnknownNCT00565396
Effectiveness Study on Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
Multi-Center,Double-Blind,Randomized,Controlled Clinical Trial of Fosinopril and/or Losartan in Patients With Chronic Kidney Disease Stage 3
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 400 (estimated)
- Sponsor
- Shanghai Municipal Health Bureau · Other Government
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether fosinopril and losartan are effective in the treatment of patients with Chronic Kidney Disease(CKD) stage 3.
Conditions
- Chronic Kidney Insufficiency
- Angiotensin-Converting Enzyme Inhibitors
- Angiotensin II Type 1 Receptor Blockers
- Proteinuria
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Fosinopril and Losartan | Fosinopril 10mg/day(oral) Losartan 50mg/day(oral) |
Timeline
- Start date
- 2004-09-01
- Completion
- 2008-07-01
- First posted
- 2007-11-30
- Last updated
- 2007-11-30
Locations
26 sites across 1 country: China
Source: ClinicalTrials.gov record NCT00565396. Inclusion in this directory is not an endorsement.